Pet Veterinary Diet Market

Pet veterinary diets are specially formulated foods prescribed by veterinarians to manage specific health conditions in dogs and cats, spanning renal and urinary care, weight management, gastrointestinal health, and dermatological conditions. Unlike standard pet food, these formulations are designed with precise nutrient profiles that support clinical management of diagnosed conditions, requiring veterinary guidance for appropriate selection and ongoing use as part of a comprehensive treatment plan.

Demand growth through the 2026-2033 window is closely tied to rising rates of chronic health conditions among companion animals, including obesity, kidney disease, and diabetes, growing pet owner willingness to invest in veterinary-recommended nutrition as part of comprehensive pet healthcare, and expanding veterinary practice recommendation of therapeutic diets as both standalone management tools and complements to pharmaceutical treatment. The broader trend of pet humanization, in which owners increasingly apply human-level healthcare expectations to their companion animals, continues to support sustained veterinary diet adoption.

The market is valued at USD 6.30 Billion in 2026, with manufacturers directing investment toward expanded condition-specific formulations and improved palatability that supports long-term dietary compliance, a persistent challenge for therapeutic pet diets. By 2033, the market is forecast to reach USD 10.73 Billion, reflecting sustained growth across established renal and urinary care applications alongside rapidly expanding weight management formulations.

• The global pet veterinary diet market is valued at USD 6.30 Billion in 2026 and is projected to reach USD 10.73 Billion by 2033, expanding at a CAGR of 7.9% across the 2026-2033 forecast period.
• Prescription Dry Food leads the product-type segment with a 54.0% share in 2026, equivalent to USD 3.40 Billion.
• Renal & Urinary Care remains the dominant application, accounting for 29.0% of global demand, or USD 1.83 Billion, in 2026.
• North America commands the largest regional share at 44.0% of the global market in 2026.
• Weight management and metabolic care formulations are emerging as the fastest-growing application through 2033.

Growth in the pet veterinary diet market is driven primarily by rising rates of chronic health conditions among companion animals, including obesity, kidney disease, and diabetes, which are increasing the population of pets for whom veterinarians recommend therapeutic dietary management as part of ongoing health care.

A second driver is growing pet owner willingness to invest in veterinary-recommended nutrition, reflecting broader pet humanization trends in which owners increasingly view companion animal healthcare through a similar lens as their own healthcare, supporting sustained willingness to pay premium pricing for clinically validated therapeutic diets.

Long-term dietary compliance remains a persistent challenge for therapeutic pet diets, as palatability differences relative to standard pet food, combined with the ongoing cost premium of veterinary diets, can lead some pet owners to discontinue therapeutic feeding before achieving the full clinical benefit intended by the prescribing veterinarian.

Additionally, the requirement for veterinary prescription and ongoing monitoring for many veterinary diet categories creates an access barrier relative to standard pet food, which pet owners can purchase without professional consultation, potentially limiting market reach among owners with less frequent veterinary engagement.

The expansion of weight management and metabolic care formulations presents a substantial opportunity, as rising companion animal obesity rates create a growing population of pets for whom weight management represents both a preventive and therapeutic dietary intervention with strong veterinary support.

A second opportunity lies in improving therapeutic diet palatability through advanced formulation technology, addressing the compliance challenges that have historically limited veterinary diet effectiveness. Manufacturers that successfully improve palatability while maintaining clinical efficacy stand to differentiate their offerings and improve long-term patient adherence, a key driver of veterinarian and pet owner satisfaction.

• By Product Type

Prescription Dry Food leads the product-type segment, accounting for 54.0% of global market value in 2026, equivalent to USD 3.40 Billion. Its leadership reflects dry food's cost-effectiveness, extended shelf life, and broad availability across the veterinary diet category. Prescription Wet & Canned Food holds a significant secondary share, often preferred for palatability or hydration-related therapeutic goals. Veterinary Treats & Supplements represent the fastest-growing product category through 2033, supporting therapeutic diet regimens with condition-specific supplementary products.

• By Application

Renal & Urinary Care forms the leading application segment, representing 29.0% of global demand in 2026, or USD 1.83 Billion, reflecting the prevalence of kidney and urinary conditions among aging companion animals and the well-established clinical evidence supporting dietary management for these conditions. Gastrointestinal Care and Dermatological Care represent significant, established application areas. Weight Management & Metabolic Care represents the fastest-growing application category, propelled by rising companion animal obesity and diabetes prevalence.

North America

North America holds the largest regional share, at 44.0% of the global market in 2026, equivalent to USD 2.77 Billion. The region's leadership reflects high pet ownership rates, strong veterinary practice infrastructure, and substantial pet owner spending on premium and therapeutic pet nutrition across the United States and Canada.

Europe

Europe accounts for 28.0% of the global market in 2026, valued at USD 1.76 Billion. Demand is supported by high pet ownership rates and well-established veterinary healthcare infrastructure across major European markets.

Asia Pacific

Asia Pacific represents 20.0% of the global market in 2026, or USD 1.26 Billion. Growth is underpinned by rising pet ownership and disposable income growth across China, Japan, and South Korea, alongside expanding veterinary care infrastructure.

Latin America

Latin America contributes 5.0% of the global market in 2026, equivalent to USD 0.32 Billion. Growth is linked to rising pet ownership and gradually expanding veterinary healthcare access in Brazil and Mexico.

Middle East & Africa

Middle East & Africa holds 3.0% of the global market in 2026, valued at USD 0.19 Billion. Growth remains at an early stage, tied to gradual expansion of veterinary healthcare infrastructure and pet ownership across the region.

The global pet veterinary diet market is moderately concentrated, with a limited number of large pet food and animal health companies holding strong positions supported by extensive veterinary relationships, clinical research investment, and established therapeutic diet product lines. Competition centers on clinical efficacy validation, palatability performance supporting long-term dietary compliance, and the strength of veterinary professional relationships and recommendation channels. Companies are increasingly differentiating through expanded condition-specific formulations and improved palatability technology rather than competing on price alone.

Key Market Players

• Hill's Pet Nutrition, Inc.
• Royal Canin
• Nestlé Purina PetCare
• Mars Petcare Inc.
• Blue Buffalo Co., Ltd.
• Virbac SA
• Diamond Pet Foods
• Affinity Petcare S.A.
• Vetoquinol S.A.
• Nutro Products, Inc.

By Product Type

• Prescription Dry Food
• Prescription Wet & Canned Food
• Veterinary Treats & Supplements
• Others

By Application

• Renal & Urinary Care
• Weight Management & Metabolic Care
• Gastrointestinal Care
• Dermatological Care
• Others

By Animal Type

• Dogs
• Cats

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa